Featured 13F manager
Patient Capital Management, LLC Samantha McLemore
Baltimore, MD 19 processed 13Fs on this site · 2021 Q4–2026 Q2
- $3.1B
- 39 Positions
- 2026 Q2
- +11.5% QoQ
- Top 5 30.5%
Portfolio
top 5 30.5% · top 10 51.3%
- RPRX - Royalty Pharma · CLASS A 6.6%
- C - Citigroup 6.4%
- GOOGL - Alphabet · CL A 6.2%
- UNH - Unitedhealth Group 6.0%
- AMZN - Amazon 5.3%
- NVDA - Nvidia 4.6%
- CVS - Cvs Health 4.2%
- NCLH - Norwegian Cruise Line 4.2%
- QXO - QXO Inc 4.0%
- ET - Energy Transfer L P 3.8%
- IAC - People 3.7%
- PGEN - Precigen 3.6%
- Other 41.4%
AUM over time
Book
| AMZN - Amazon | 6.17% | Reduce −2.5% | 609,896 | $219.39 | $134M | −15,432 | +$17M |
| QXO - QXO Inc | 5.67% | Reduce −0.1% | 7,733,030 | $15.90 | $123M | −8,817 | +$866K |
| GOOGL - Alphabet · CL A | 5.20% | Reduce 0.0% | 595,490 | $189.30 | $113M | −246 | +$14M |
| C - Citigroup | 5.01% | Reduce 0.0% | 1,541,308 | $70.39 | $108M | −550 | +$12M |
| ET - Energy Transfer L P | 4.60% | Reduce −3.9% | 5,091,882 | $19.59 | $100M | −204,948 | +$15M |
| META - Meta Platforms · CL A | 3.99% | Reduce −0.1% | 147,628 | $585.51 | $86M | −196 | +$2M |
| EXPE - Expedia Group | 3.80% | Reduce −31.7% | 442,429 | $186.33 | $82M | −204,900 | −$13M |
| NVDA - Nvidia | 3.77% | Reduce 0.0% | 608,563 | $134.29 | $82M | −165 | +$8M |
| GM - General Mtrs | 3.76% | Reduce −1.2% | 1,531,144 | $53.27 | $82M | −18,930 | +$12M |
| RPRX - Royalty Pharma · CLASS A | 3.38% | Add +40.9% | 2,875,089 | $25.51 | $73M | +833,894 | +$16M |
| IAC - IAC Inc | 3.32% | Add +0.2% | 1,667,261 | $43.14 | $72M | +3,727 | −$18M |
| UAL - United Airls | 3.25% | Reduce −27.9% | 725,244 | $97.10 | $70M | −280,313 | +$13M |
| OMF - Onemain | 3.04% | Reduce −10.6% | 1,263,145 | $52.13 | $66M | −150,070 | −$672K |
| SOFI - SOFI Technologies | 3.02% | Reduce −26.6% | 4,251,680 | $15.40 | $65M | −1,544,007 | +$20M |
| SDRL - Seadrill 2021 | 3.01% | Add +63.5% | 1,676,777 | $38.93 | $65M | +651,132 | +$25M |
| NCLH - Norwegian Cruise | 2.95% | Reduce −11.4% | 2,483,809 | $25.73 | $64M | −318,141 | +$6M |
| BIIB - Biogen | 2.92% | Add +61.7% | 413,960 | $152.92 | $63M | +158,018 | +$14M |
| UBS - UBS Group AG | 2.86% | Add +1.0% | 2,042,420 | $30.32 | $62M | +20,401 | −$574K |
| KOS - Kosmos Energy | 2.71% | Add +81.6% | 17,147,729 | $3.42 | $59M | +7,707,707 | +$21M |
| BABA - Alibaba Group | 2.70% | Add +4.7% | 689,712 | $84.79 | $58M | +30,986 | −$11M |
| CVS - Cvs Health | 2.69% | Add +68.8% | 1,298,429 | $44.89 | $58M | +529,333 | +$10M |
| DAL - Delta Air Lines Del | 2.64% | Reduce −25.0% | 947,509 | $60.50 | $57M | −316,065 | −$7M |
| ILMN - Illumina | 2.53% | Reduce −0.4% | 409,955 | $133.63 | $55M | −1,600 | +$1M |
| PLAY - Dave & Busters Entmt | 2.39% | Add +36.6% | 1,777,260 | $29.19 | $52M | +476,662 | +$8M |
| COIN - Coinbase Global · CL A | 2.33% | Add +15.0% | 203,401 | $248.30 | $51M | +26,569 | +$19M |
| CROX - Crocs | 2.25% | Add +16.9% | 445,227 | $109.53 | $49M | +64,258 | −$6M |
| MAT - Mattel | 2.07% | Reduce −0.2% | 2,532,472 | $17.73 | $45M | −4,173 | −$3M |
| GOOS - Canada Goose | 1.78% | Add +3.4% | 3,854,520 | $10.03 | $39M | +128,133 | −$8M |
| PTON - Peloton Interactive · CL A | 1.53% | Reduce −24.5% | 3,817,374 | $8.70 | $33M | −1,237,958 | +$10M |
| GBTC - Grayscale Bitcoin Trust | 1.15% | Add +215.5% | 305,603 | $81.58 | $25M | +208,752 | +$20M |
| EXE - Expand Energy | 1.09% | Add +0.1% | 236,911 | $99.55 | $24M | +227 | +$4M |
| PGEN - Precigen | 0.92% | Reduce −0.3% | 17,881,246 | $1.12 | $20M | −56,448 | +$3M |
| JPM - Jpmorgan Chase & | 0.33% | Hold | 29,386 | $239.71 | $7M | — | — |
| TNL - Travel Plus Leisure | 0.27% | Reduce −86.8% | 116,599 | $50.45 | $6M | −767,534 | −$35M |
| Everi | 0.19% | Reduce −17.2% | 300,310 | $13.51 | $4M | −62,310 | −$708K |
| JD — · CL A | 0.16% | New | 100,000 | $34.67 | $3M | +100,000 | +$3M |
| WST - Western Alliance Bancorp | 0.11% | Reduce −88.0% | 28,282 | $83.54 | $2M | −207,210 | −$18M |
| TEVA - Teva Pharmaceutical Inds | 0.10% | Hold | 100,000 | $22.04 | $2M | — | — |
| FISV - Fiserv | 0.10% | Reduce −92.4% | 10,042 | $205.42 | $2M | −122,828 | −$22M |
| SPY - Spdr S&P 500 ETF Tr | 0.09% | Add +133.0% | 3,463 | $586.01 | $2M | +1,977 | +$1M |
| LEN.B — · CL B | 0.08% | Hold | 12,500 | $132.15 | $2M | — | — |
| APA — | 0.05% | New | 50,000 | $23.09 | $1M | +50,000 | +$1M |
| BRLT - Brilliant Earth Group · CL A | 0.01% | Reduce −58.6% | 100,000 | $2.10 | $210K | −141,445 | −$307K |
Filings history
19 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 40 | $3.1B | +11.5% | 13F-HR | 8/13/2026 | 000185479426000005 |
| 2026 Q1 | 40 | $2.7B | +5.6% | 13F-HR | 5/14/2026 | 000185479426000004 |
| 2025 Q4 | 40 | $2.6B | +3.7% | 13F-HR | 2/13/2026 | 000185479426000003 |
| 2025 Q3 | 41 | $2.5B | +12.7% | 13F-HR | 10/30/2025 | 000185479425000004 |
| 2025 Q2 | 40 | $2.2B | +13.9% | 13F-HR | 8/13/2025 | 000108514625004963 |
| 2025 Q1 | 39 | $1.9B | −10.2% | 13F-HR | 5/14/2025 | 000108514625003124 |
| 2024 Q4 | 43 | $2.2B | +6.4% | 13F-HR | 2/14/2025 | 000108514625001553 |
| 2024 Q3 | 41 | $2B | +8.2% | 13F-HR | 11/14/2024 | 000108514624005800 |
| 2024 Q2 | 40 | $1.9B | −8.3% | 13F-HR | 8/14/2024 | 000108514624003874 |
| 2024 Q1 | 42 | $2.1B | +8.8% | 13F-HR | 5/15/2024 | 000108514624002548 |
| 2023 Q4 | 43 | $1.9B | +10.8% | 13F-HR | 2/14/2024 | 000108514624001375 |
| 2023 Q3 | 42 | $1.7B | −5.2% | 13F-HR | 11/14/2023 | 000108514623004442 |
| 2023 Q2 | 44 | $1.8B | +702.2% | 13F-HR | 8/14/2023 | 000108514623003400 |
| 2023 Q1 | 42 | $224M | +8.7% | 13F-HR | 5/15/2023 | 000108514623002385 |
| 2022 Q4 | 43 | $206M | +3.0% | 13F-HR | 2/14/2023 | 000108514623001252 |
| 2022 Q3 | 42 | $200M | −11.5% | 13F-HR | 11/14/2022 | 000108514622004043 |
| 2022 Q2 | 42 | $226M | −23.4% | 13F-HR | 8/15/2022 | 000108514622003092 |
| 2022 Q1 | 45 | $295M | −15.0% | 13F-HR | 5/16/2022 | 000108514622002149 |
| 2021 Q4 | 43 | $347M | — | 13F-HR | 2/14/2022 | 000108514622001017 |
About
Patient Capital Management, LLC
19 processed 13Fs on this site · 2021 Q4–2026 Q2